MyAverix Finance
F · Healthcare
Oruka Therapeutics, Inc. (HQ1)
Biotechnology
Oruka Therapeutics, Inc. (HQ1) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $1.92B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HQ1
Oruka Therapeutics, Inc. (HQ1) — FAQ
What is Oruka Therapeutics, Inc.'s market cap?
Oruka Therapeutics, Inc. (HQ1) has a reported market cap of $1.92B (data as of 2026-03-29).
What is HQ1's P/E ratio?
The price-to-earnings (P/E) ratio for Oruka Therapeutics, Inc. (HQ1) is 18.00 (data as of 2026-03-29).
Does Oruka Therapeutics, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Oruka Therapeutics, Inc. (HQ1). Check the MyAverix Finance app for the latest dividend data.
What sector is Oruka Therapeutics, Inc. in?
Oruka Therapeutics, Inc. (HQ1) is classified in the Healthcare sector (Biotechnology industry).
What exchange is HQ1 listed on?
HQ1 is listed on F.
What is Oruka Therapeutics, Inc.'s net margin?
Oruka Therapeutics, Inc. (HQ1) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.